Impact of age on immune checkpoint blockade tolerability across malignancies: A single institution review

Authors :: Jennifer Johnson
Reetu Mukherji
Sharon Li
Mario Caldararo
Sheel A. Patel
Marlana Orloff
Sean Clark-Garvey
Philip Margiotta
Ryan M. Weight
Daniel S. Altman
Thomas Holden
Source :: Journal of Clinical Oncology. 36:e15069-e15069
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e15069Background: Immune checkpoint inhibitors have become an integral part of treatment for a variety of malignancies. Given the favorable side effect profile compared to chemotherapy, there is in...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
Side effect
business.industry
Immune checkpoint inhibitors
medicine.medical_treatment
Immune checkpoint
Blockade
Tolerability
Internal medicine
medicine
Single institution
business

Tools